Originally published April 7 2005
Vision loss linked to Viagra use in 14 cases
by Mike Adams, the Health Ranger, NaturalNews Editor
Fourteen men who took Viagra have developed a condition known as nonarteritic ischemic optic neuropathy (NAION), a condition that can cause permanent loss of vision. The men developed symptoms of blurred vision and vision loss from 24 to 36 hours after using the erection drug. Researchers believe that heart disease risk factors are strongly correlated to developing NAION.
- In a new study, US researchers describe seven patients who developed nonarteritic ischemic optic neuropathy (NAION), an eye problem that can result in permanent vision loss, after taking Viagra (sildenafil) for erection difficulties.
- Combined with past reports, this study brings the total number of sildenafil-related NAION cases to 14.
- "For years, we've known that some men who take Viagra will experience temporary color changes in their vision and see things as blue or green," study co-author Dr. Howard D. Pomeranz, from the University of Minnesota in Minneapolis, said in a statement.
- "NAION is a much more serious condition because it can lead to permanent vision loss."
- With the exception of one patient whose symptoms began 24 to 36 hours after using Viagra, the patients developed symptoms within 24 hours of use.
- In all patients, the initial symptoms were blurred vision and some degree of vision loss.
- In one patient, both eyes were affected, whereas in the remainder, just one was involved.
- All of the patients had one or more heart disease risk factors.
- Three patients had preexisting eye problems that may have increased their risk of NAION.
- Pomeranz told Reuters Health that Viagra's association with NAION appears to involve all drugs of this type, as reports have surfaced implicating Cialis (tadalafil) use as well.
- "At this point, there are not enough data to support performing an ophthalmologic exam on every patient being considered for" Viagra treatment, Pomeranz noted.
- Still, he said that doctors prescribing the drug should be aware of the association with NAION and consider an exam for patients with several heart disease risk factors.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml